
Explore novel C0702 restricted epitope on MAGE A1 and its preclinical development for enhanced anti-tumor T-cell responses in cancer immunotherapy.

Explore novel CAR-T cell engineering using piggyBac transposon for solid tumors. Learn about memory-rich T cells, manufacturing processes, and potential clinical applications in cancer immunotherapy.

Explore ecological dynamics in cancer-immune interactions, focusing on evolution, complex systems, and immunotherapy. Gain insights into genome instability and adaptive immune responses.

Explore pre-clinical research on a novel PD-L1 B cell epitope peptide vaccine, PDL1-Vaxx, presented by Jay Overholser from Ohio State University Wexner Medical Center.

Explore hypoxia biomarkers for personalized cancer treatments. Learn about tumor microenvironments, prognosis impacts, and treatment resistance. Gain insights into targeting hypoxia for improved patient outcomes.